METHOD TO IDENTIFY OPTIMUM CORONARY ARTERY DISEASE TREATMENT
    1.
    发明申请
    METHOD TO IDENTIFY OPTIMUM CORONARY ARTERY DISEASE TREATMENT 审中-公开
    识别最佳冠状动脉疾病治疗的方法

    公开(公告)号:US20160292372A1

    公开(公告)日:2016-10-06

    申请号:US14442517

    申请日:2013-11-15

    IPC分类号: G06F19/00 G06N3/04 G06N3/08

    CPC分类号: G16H50/20 G06N3/0472 G06N3/08

    摘要: A method of identifying an optimum treatment for a patient suffering from coronary artery disease, comprising: (i) providing patient information selected from: (a) status in the patient of one or more coronary disease associated biomarkers; (b) one or more items of medical history information selected from prior condition history, intervention history and medication history; (c) one or more items of diagnostic history, if the patient has a diagnostic history; and (d) one or more items of demographic data; (ii) aggregating the patient information in: (a) a Bayesian network; (b) a machine learning and neural network; (c) a rule-based system; and (d) a regression-based system; (iii) deriving a predicted probabilistic adverse event outcome for each intervention comprising percutaneous coronary intervention by placement of a bare metal stent, or a drug-coated stent; or by coronary artery bypass grafting; and (iv) determining the intervention having the lowest predicted probabilistic adverse outcome.

    摘要翻译: 一种鉴定患有冠状动脉疾病的患者的最佳治疗的方法,包括:(i)提供患者信息,所述患者信息选自:(a)患者中一种或多种冠状动脉疾病相关生物标志物的状态; (b)从先前情况史,干预史和用药史选择的一项或多项病史信息; (c)患者具有诊断史的一项或多项诊断史; 和(d)一个或多个人口统计数据项目; (ii)在以下方面聚合患者信息:(a)贝叶斯网络; (b)机器学习和神经网络; (c)基于规则的制度; 和(d)基于回归的系统; (iii)通过放置裸金属支架或药物涂层的支架,导出包括经皮冠状动脉介入的每个干预的预测概率不良事件结果; 或通过冠状动脉旁路移植术; 和(iv)确定具有最低预测概率不良结果的干预。

    Method to identify optimum coronary artery disease treatment

    公开(公告)号:US11450431B2

    公开(公告)日:2022-09-20

    申请号:US14442517

    申请日:2013-11-15

    摘要: A method of identifying an optimum treatment for a patient suffering from coronary artery disease, comprising: (i) providing patient information selected from: (a) status in the patient of one or more coronary disease associated biomarkers; (b) one or more items of medical history information selected from prior condition history, intervention history and medication history; (c) one or more items of diagnostic history, if the patient has a diagnostic history; and (d) one or more items of demographic data; (ii) aggregating the patient information in: (a) a Bayesian network; (b) a machine learning and neural network; (c) a rule-based system; and (d) a regression-based system; (iii) deriving a predicted probabilistic adverse event outcome for each intervention comprising percutaneous coronary intervention by placement of a bare metal stent, or a drug-coated stent; or by coronary artery bypass grafting; and (iv) determining the intervention having the lowest predicted probabilistic adverse outcome.